肿瘤营养治疗的发展与进步

doi:10.3969/j.issn.1006-7795.2021.03.028

首都医科大学学报 ›› 2021, Vol. 42 ›› Issue (3): 499-502.doi: 10.3969/j.issn.1006-7795.2021.03.028

肿瘤营养治疗的发展与进步

于恺英^1,2, 王晓琳^2,3, 石汉平^1,2,3*

1.首都医科大学附属北京世纪坛医院胃肠外科,北京 100038;
2.肿瘤代谢与营养北京市国际科技合作基地,北京 100038;
3.首都医科大学附属北京世纪坛医院临床营养科,北京 100038

收稿日期:2021-02-22 出版日期:2021-06-21 发布日期:2021-06-16
通讯作者: *E-mail:shihp@ccmu.edu.cn
基金资助:
国家重点研发计划项目(2017YFC1309203)。

Development and progress of cancer nutrition therapy

Yu Kaiying^1,2, Wang Xiaolin^2,3, Shi Hanping^1,2,3*

1. Department of Gastrointestinal Surgery,Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China;
2. Beijing International Science and Technology Cooperation Base of Cancer Metabolism and Nutrition, Beijing 100038, China;
3. Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China

Received:2021-02-22 Online:2021-06-21 Published:2021-06-16
Contact: *E-mail:shihp@ccmu.edu.cn
Supported by:
National Key Research and Development Program of China(2017YFC1309203).

摘要/Abstract

摘要： 恶性肿瘤是人类主要的健康问题、头号死亡原因,严重威胁人民身心健康、经济发展、社会稳定及国家安全。营养不良是肿瘤患者最常见的合并症,是肿瘤患者独立的死亡风险因素,不仅导致不良临床结局(生存时间缩短、生活质量下降),而且造成巨大的社会经济负担。所以,治疗肿瘤患者的营养不良意义重大。与日常饮食相比,特殊医学用途配方食品(以下简称特医食品)具有一些特殊的优势,口服营养补充是最便捷、最便宜的营养治疗方法,具有促进疾病康复、缩短住院时间、节约医疗费用的显著作用。全面提高对肿瘤营养重要性的认识,并在临床工作中践行一线治疗原则,大力发展我国特医食品产业,尤其是肿瘤特医食品,必将整体大幅度提高我国肿瘤治疗水平,显著节约医疗费用。

关键词: 恶性肿瘤, 营养治疗, 特殊医学用途配方食品

Abstract: Malignant tumor is the main health problem/concern and the one of the leading causes of death in human being, and it seriously threatens people's physical and mental health, economic development, social stability, and national security. Malnutrition is the most common complication in the patients with cancer and an independent risk factor for death in the patient with cancer, leading to not only adverse clinical outcomes (shortened survival time and reduced quality of life), but also a significant socio-economic burden. Therefore, treating malnutrition in the cancer patients is of great significance. Compared with daily diet, food for special medical purpose has some special advantages. Numerous studies have proved that oral nutritional supplement is the most convenient and cheapest nutritional treatment methods, which can promote disease rehabilitation, shorten the length of hospital stay and save medical costs. It is necessary to deepen the understanding of the importance of cancer nutrition, advance the practice of the first-line treatment in clinical work, and develop China's food for special medical purpose, especially cancer special medical food, which will greatly improve the overall level of cancer treatment in China and significantly save medical costs.

Key words: malignant tumor, nutritional therapy, food for special medical purpose

中图分类号:

R459.3

于恺英, 王晓琳, 石汉平. 肿瘤营养治疗的发展与进步[J]. 首都医科大学学报, 2021, 42(3): 499-502.

Yu Kaiying, Wang Xiaolin, Shi Hanping. Development and progress of cancer nutrition therapy[J]. Journal of Capital Medical University, 2021, 42(3): 499-502.

参考文献

[1] International Agency for Research on Cancer (IARC).Latest global cancer data:cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020[EB/OL].(2020-1-16)[2021-2-22].http://www.iarc.who.int/faq/latest-global-cancer-data-2020-qa/.
[2] 宋春花, 王昆华, 郭增清, 等.中国常见恶性肿瘤患者营养状况调查[J].中国科学:生命科学,2020,50(12):1437-1452.
[3] Warburg O.The chemical constitution of respiration ferment[J].Science,1928,68(1767):437-443.
[4] Tajan M, Vousden K H.Dietary approaches to cancer therapy[J].Cancer Cell, 2020,37(6):767-785.
[5] Weber D D, Aminzadeh-Gohari S, Tulipan J, et al.Ketogenic diet in the treatment of cancer-Where do we stand?[J].Mol Metab, 2020,33:102-121.
[6] Bose S, Allen A E, Locasale J W.The molecular link from diet to cancer cell metabolism[J].Mol Cell,2020,78(6):1034-1044.
[7] Downer S, Berkowitz S A, Harlan T S, et al.Food is medicine:actions to integrate food and nutrition into healthcare[J].BMJ, 2020,369:2482.
[8] Kanarek N, Petrova B, Sabatini D M.Dietary modifications for enhanced cancer therapy[J].Nature,2020,579(7800):507-517.
[9] Rock C L, Thomson C, Gansler T,et al.American Cancer Society guideline for diet and physical activity for cancer prevention[J].CA Cancer J Clin, 2020,70(4):245-271.
[10] 黎介寿.肿瘤营养学的兴起及临床应用[J].肠外与肠内营养,2004,11(1):1-2.
[11] 石汉平, 凌文华,李薇.肿瘤营养学[M].北京:人民卫生出版社, 2012.
[12] 石汉平.肿瘤营养疗法[J].中国肿瘤临床, 2014,41(18):1141-1145.
[13] 石汉平.肿瘤新疗法——代谢调节治疗[J/CD].肿瘤代谢与营养电子杂志,2014,1(1):3-5.
[14] 石汉平.整体营养疗法[J/CD].肿瘤代谢与营养电子杂志,2017,4(2):130-135.
[15] 石汉平.肿瘤是一种代谢性疾病[J/CD].肿瘤代谢与营养电子杂志,2018,5(2):111-116.
[16] 于恺英, 刘俐惠, 石汉平.营养状况是基本生命体征[J/CD].肿瘤代谢与营养电子杂志,2019,6(4):391-395.
[17] 石汉平.营养治疗是肿瘤的一线治疗[J].临床药物治疗杂志,2019,17(4):20-25.
[18] 石汉平.重视肿瘤营养学的学科发展[J].中国医学前沿杂志:电子版, 2016,8(1):1-3.
[19] 石汉平,赵青川,王昆华,等.营养不良的三级诊断[J/CD].肿瘤代谢与营养电子杂志,2015,2(2):31-36.
[20] 石汉平,许红霞,李苏宜,等.营养不良的五阶梯治疗[J/CD].肿瘤代谢与营养电子杂志,2015,2(1):29-33.
[21] 石汉平.营养治疗的疗效评价[J/CD].肿瘤代谢与营养电子杂志,2017,4(4):364-370.
[22] 石汉平,李增宁,王昆华,等.中国抗癌协会肿瘤营养与支持治疗专业委员会.营养管理新模式—HCH[J/CD].肿瘤代谢与营养电子杂志,2015,2(3):23-26.
[23] 石汉平,杨剑,张艳.肿瘤患者营养教育[J/CD].肿瘤代谢与营养电子杂志,2017,4(1):1-6.
[24] Schuetz P, Fehr R, Baechli V, et al.Individualised nutritional support in medical inpatients at nutritional risk:a randomised clinical trial[J].Lancet, 2019,393(10188):2312-2321.
[25] Pedrazzoli P, Caccialanza R, Cotogni P, et al.The advantages of clinical nutrition use in oncologic patients in Italy:real world insights[J].Healthcare (Basel), 2020,8(2):125.
[26] Guan H, Chen S, Huang Q.Effects of enteral immunonutrition in patients undergoing pancreaticoduodenectomy:a Meta-analysis of randomized controlled trials[J].Ann Nutr Metab,2019,74(1):53-61.
[27] Lu Z, Fang Y, Liu C,et al.Early interdisciplinary supportive care in patients with previously untreated metastatic esophagogastric cancer:a phase III randomized controlled trial[J].J Clin Oncol,2021,39(7):748-756.
[28] Tyler R, Barrocas A, Guenter P, et al.ASPEN value project scientific advisory council.Value of nutrition support therapy:impact on clinical and economic outcomes in the united states[J].JPEN J Parenter Enteral Nutr, 2020,44(3):395-406.
[29] Philipson T J, Snider J T, Lakdawalla D N,et al.Impact of oral nutritional supplementation on hospital outcomes[J].Am J Manag Care, 2013,19(2):121-128.
[30] 中国抗癌协会.中国肿瘤营养治疗指南(2020)[M].北京:人民卫生出版社,2020.
[31] 中国抗癌协会肿瘤营养专业委员会.恶性肿瘤营养不良的特征[J/CD].肿瘤代谢与营养电子杂志, 2020, 7(3):276-282.
[32] De van der Schueren M A E, Laviano A, Blanchard H,et al.Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy:current evidence and guidance for design of future trials[J].Ann Oncol, 2018,29(5):1141-1153.
[33] Klek S, Scislo L, Walewska E,et al.Enriched enteral nutrition may improve short-term survival in stage IV gastric cancer patients:a randomized, controlled trial[J].Nutrition, 2017,36:46-53.
[34] Wu J, Li G, Li L,et al.Asparagine enhances LCK signalling to potentiate CD8+ T-cell activation and anti-tumour responses[J].Nat Cell Biol, 2021,23(1):75-86.
[35] Caccialanza R, Goldwasser F, Marschal O, et al.Unmet needs in clinical nutrition in oncology:a multinational analysis of real-world evidence[J].Ther Adv Med Oncol, 2020,12:1758835919899852.

肿瘤营养治疗的发展与进步

Development and progress of cancer nutrition therapy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

本文评价

[1]	张志丽, 郭彩霞. 头颈部恶性肿瘤术后急性肺栓塞临床特点及危险因素分析[J]. 首都医科大学学报, 2022, 43(5): 787-791.
[2]	王维, 张紫寒, 翟妍, 桑翠琴, 王淑珍. 子宫体、乳腺双原发癌的临床病理特征[J]. 首都医科大学学报, 2019, 40(6): 857-862.
[3]	姬忠贺, 刘洋, Yutaka Yonemura, 李雁. 5-氨基酮戊酸光动力学诊断腹膜转移癌的研究进展[J]. 首都医科大学学报, 2018, 39(3): 469-475.
[4]	孙小红, 孔为民, 马正君. 行为干预对妇科恶性肿瘤治疗后下肢淋巴水肿患者的作用[J]. 首都医科大学学报, 2016, 37(6): 826-829.
[5]	赵京阳, 顾梅, 朱长雨, 党受涛. 全肠外营养在消化道恶性肿瘤术后患者中的应用分析[J]. 首都医科大学学报, 2014, 35(5): 657-659.
[6]	张旭乡;曲冬懿;曲秋懿. 泪囊恶性肿瘤的诊治[J]. 首都医科大学学报, 2007, 28(3): 415-417.
[7]	陈升平;王香平;周莲娥. 明胶酶-2、明胶酶-9与卵巢上皮性肿瘤[J]. 首都医科大学学报, 2006, 27(4): 533-535.
[8]	张俊玲;王宝玲;李颜玲;左桂莲. 北京天坛地区恶性肿瘤死亡原因分析[J]. 首都医科大学学报, 2003, 24(3): 272-274.
[9]	王娟;朱玉群;杨昭徐;张磊;李欣欣. 血清CA242与CEA联合检测对消化系恶性肿瘤的诊断价值[J]. 首都医科大学学报, 2000, 21(4): 292-294.
[10]	高居忠;朱章菱;肖白;王跃;迟闺珠;于莎莎;刘复兴;李正廷;张愚. 上皮源性恶性肿瘤患者p16/MTS1抑癌基因失活研究[J]. 首都医科大学学报, 2000, 21(1): 33-36.
[11]	熊治权. 小肠原发性恶性肿瘤[J]. 首都医科大学学报, 1992, 13(3): 212-215.